Age-Related Macular Degeneration (AMD) is a progressive ocular condition affecting the macula—the highly specialized central area of the retina responsible for sharp, high-acuity, straight-ahead vision. The macula enables us to read, drive, recognize friends' faces, read smartphones, and perceive fine details.
When macular degeneration occurs, peripheral vision remains intact, meaning total blindness does not occur, but central vision becomes blurred, distorted, or shadowed. With modern retinal imaging and anti-VEGF pharmacotherapy, sight can be preserved and often significantly restored when diagnosed early.
1. What is Age-Related Macular Degeneration (AMD)?
The retina is the light-sensitive neural tissue lining the back of the eye. At the exact anatomical center of the retina lies the macula, packed with millions of light-sensing cone photoreceptor cells.
With aging, cellular metabolic turnover slows down. Waste byproducts of cellular metabolism (lipofuscin and lipids) accumulate between the Retinal Pigment Epithelium (RPE) and Bruch's membrane, forming tiny yellow deposits called drusen. As drusen enlarge, they compromise oxygenation and nutrient delivery to photoreceptors, leading to macular degeneration.
2. Symptoms & Early Warning Signs
In early stages, AMD may cause minimal or no noticeable symptoms. As the condition advances, patients often report:
- Blurred or Distorted Central Vision: Printed text or digital screens look indistinct or hazy.
- Metamorphopsia (Distorted Straight Lines): Door frames, window blinds, tiles, or lines on a page appear wavy, bent, or kinked.
- Central Scotoma: A dark, blurry, or blind spot in the middle of your visual field.
- Difficulty Recognising Faces: Looking directly at a person's face may reveal an unclear center while their surroundings remain visible.
- Impaired Color and Contrast Perception: Colors appear washed out, and navigating dim environments becomes difficult.
3. Dry AMD vs Wet AMD Explained
Dry Macular Degeneration
Prevalence: 85%–90% of AMD patients.
Mechanism: Slow, gradual accumulation of drusen and thinning of the retinal pigment epithelium and photoreceptors.
Progression: Develops slowly over many years. In late stages, it may cause Geographic Atrophy (GA).
Management: AREDS 2 antioxidant vitamin supplements, smoking cessation, UV protection, and frequent Amsler grid monitoring.
Wet Macular Degeneration
Prevalence: 10%–15% of AMD cases, but responsible for 90% of severe vision loss.
Mechanism: Oxygen deprivation triggers abnormal new blood vessel growth beneath the retina (Choroidal Neovascularization / CNV).
Progression: Can progress rapidly within weeks or days as leaky vessels bleed and exudate fluid into the macula.
Management: Urgent, routine Intravitreal Anti-VEGF Injections to stop leakage, clear bleeding, and preserve central vision.
4. Advanced Diagnostics at Advanced Retina Care
Accurate diagnosis is paramount. At our Panjagutta center, Dr. Anina Abraham utilizes advanced non-invasive imaging technologies:
- High-Definition Spectral-Domain OCT: Micron-level optical cross-sections of the retina that visualize drusen, subretinal fluid, intraretinal cysts, and pigment epithelial detachments (PED).
- OCT Angiography (OCT-A): Dye-free, non-invasive vascular flow imaging that maps choroidal neovascular membranes (CNV) within seconds.
- Fundus Fluorescein Angiography (FFA) & ICG Angiography: When required to evaluate active leaking points, Polypoidal Choroidal Vasculopathy (PCV), or occult vascular complexes.
5. Anti-VEGF Eye Injections Protocol
For Wet AMD, Intravitreal Anti-VEGF Injections represent the worldwide standard of medical care.
Vascular Endothelial Growth Factor (VEGF) is a biological signaling protein produced when retinal cells are starved of oxygen. Anti-VEGF drugs bind directly to this molecule, preventing abnormal blood vessel proliferation and drying up subretinal fluid.
What to Expect During the Procedure:
- The procedure is performed inside a dedicated sterile minor operation theater.
- Topical anesthetic eye drops are instilled to completely numb the eye.
- The eye and eyelids are sterilized with an antiseptic solution (Povidone Iodine).
- Using an ultra-fine micro-needle (30G or 32G), the medication is gently administered into the vitreous gel. The injection takes less than 2 seconds and is virtually painless.
- Patients can return home immediately after the procedure.
6. Available Injections in Hyderabad
Depending on the subtype of macular disease, fluid characteristics on OCT, and individual budgetary needs, several approved Anti-VEGF and dual-acting therapies are available:
- Ranibizumab (Accentrix / Lucentis / Razumab): A proven, potent antibody fragment specifically designed for ocular use. Razumab is an approved biosimilar providing cost-effective therapy.
- Aflibercept (Eylea): A VEGF-trap molecule with strong binding affinity, effective for stubborn macular fluid and polypoidal vasculopathy.
- Faricimab (Vabysmo): The newest dual-action bispecific antibody that neutralizes both VEGF-A and Angiopoietin-2 (Ang-2), stabilizing blood vessels and allowing extended treatment intervals up to 16 weeks.
- Brolucizumab (Pagenax): A single-chain antibody fragment offering intense fluid resolution in selected resistant cases.
7. Nutrition, AREDS 2 Formula & Home Monitoring
For patients with Dry AMD or early AMD in the fellow eye, the following evidence-backed preventive measures are crucial:
- AREDS 2 Nutritional Supplements: Formulated with Lutein, Zeaxanthin, Vitamin C, Vitamin E, Zinc, and Copper. This formula has been clinically demonstrated to reduce the risk of progressing to advanced wet AMD by 25%.
- Dietary Choices: Increase consumption of dark leafy greens (spinach, methi, kale), colorful vegetables, citrus fruits, and omega-3 rich fish or flaxseeds.
- Strict Smoking Cessation: Smoking increases the risk of AMD progression by up to 4 times and impairs retinal oxygenation.
- Daily Amsler Grid Testing: Regularly test each eye individually to detect new waviness or blind spots immediately.
8. Treatment Cost & Why Choose Advanced Retina Care
The cost of macular degeneration treatment in Hyderabad varies depending on the choice of anti-VEGF medication (biosimilar vs imported molecules) and the number of treatment sessions needed.
At Advanced Retina Care in Panjagutta, Hyderabad:
- Expert Retina Specialist: Led by Dr. Anina Abraham, with over two decades of dedicated vitreoretinal experience.
- Transparent Pricing: Clear, upfront counseling on medication options suited to your clinical condition and financial preference.
- Cashless Insurance Support: Assistance with health insurance claims and corporate medical benefits for intravitreal procedures.
- Immediate Emergency Triage: Fast-track appointments for patients presenting with sudden central visual decline.
Dr. Anina Abraham, MS, FRCS
Senior Eye Surgeon & Vitreoretinal Specialist
Alumnus of L V Prasad Eye Institute (LVPEI)
A recognized expert in retinal vascular diseases, age-related macular degeneration, diabetic retinopathy, and advanced micro-incision vitrectomy surgery.